MarketsandMarkets Presents
Immunohistochemistry Market – Industry Dynamics | Future Growth Prospects | Market Segmentation http://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market121632939.html
The report "Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021", The global immunohistochemistry market is expected to reach USD 2.12 Billion by 2021 from USD 1.48 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021. Browse: 181 market data tables 44 figures 225 pages And in-depth TOC on ÍžImmunohistochemistry MarketÍ&#x;
Download The PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=121632939 Growing prevalence of cancer and rapidly increasing geriatric population across the globe are the major factors driving the growth of the immunohistochemistry market. http://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market121632939.html
Other important factors driving market growth include increasing healthcare spending and improving healthcare infrastructure resulting in an increase in the number of hospitals and diagnostic laboratories. Talk To Our Research Experts@ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=121632939
The growing consolidation, incorporation of nanotechnology in immunohistochemistry, adoption of multiplex arrays, and automation in this market are the key trends in the market. Rapid growth in the developing countries across APAC and Latin America and the
increasing demand for personalized medicine offer significant growth opportunities for players in the immunohistochemistry market.
http://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market121632939.html
Market Segmentation:
The global immunohistochemistry market is segmented based on product, application, end user, and region.
Based on product, the market is segmented into antibodies, reagents, equipment, and kits.
The antibodies segment is further divided into primary antibodies and secondary antibodies.
The reagents segment is further divided into histological stains, blocking sera & reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes, and diluents. The equipment segment is further divided into slide staining systems, tissue microarrays, tissue processing systems, scanners, and others. http://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market121632939.html
Based on application, the immunohistochemistry market is segmented into diagnostics and drug testing. The diagnostics segment is further divided into cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases.
Based on end user, the market is segmented into hospitals & diagnostic laboratories,
research institutions, and other end users.
This report also provides market information across major regional segments, namely,
North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further segmented at a country level.
http://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market121632939.html
The markets in Asia-Pacific, Latin America, and the Middle East & Africa are expected to register high growth during the forecast period owing to the presence of a large pool of cancer patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, and increasing prevalence of chronic diseases in emerging countries in this region. Developing countries such as India, China, and Brazil will be the focal point of growth in these respective regional markets.
The global immunohistochemistry market is consolidated at the top. Small market players operating at regional and local levels are challenging the market shares of leading players.
In order to maintain their market shares, leading players are continuously developing new technologies and upgrading their existing products to enhance their product portfolios.
http://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market121632939.html
Increasing competition in this market is expected to drive innovation, thereby helping the industry to overcome existing challenges and at the same time address compliance issues and demand of end users.
Target Audience: • • • • • • • • •
Manufacturing Companies of Immunohistochemistry Products Hospitals and Clinics Nursing Homes Assisted Living Facilities Healthcare Insurance Providers Market Research & Consulting Firms Venture Capitalist and Investors Research Institutes Contract Research Organizations
http://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market121632939.html
About MarketsandMarkets™ Marketsa dMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide co pa ies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach Marketsa dMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at Marketsa dMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. Marketsa dMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. Marketsa dMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. Marketsa dMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
http://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market121632939.html
Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets